Sakar Healthcare Limited — Board Meeting, 25-07-2025: Outcome of Board Meeting

Sakar Healthcare's board approved Q1 FY26 consolidated results: Revenue from operations ₹52.74 Cr, net profit ₹4.67 Cr, with basic EPS of ₹2.11.

The 21st Annual General Meeting is set for September 23, 2025, to be held virtually with e-voting.

Three new Independent Directors (Ms. Samdani, Ms. Kothari, Ms. Patel) were appointed, alongside key senior management: Mr. Sudhir Ghule (COO), Mr. Raviraj Karia (SVP Finance), and Mr. Nimesh Suthar (SVP International Business).

Of the ₹8.64 Cr raised via convertible warrants, ₹1.55 Cr repaid loans and ₹1.85 Cr funded capital expenditure. The remaining ₹5.25 Cr for capex will be utilized within six months.